Dihydrotestosterone (DHT) is a key androgenic marker providing critical insights into androgen metabolism and its implications in female health. DHT, a biologically active metabolite of testosterone, is formed primarily in peripheral tissues through the action of the enzyme 5-alpha-reductase. Despite being commonly associated with male physiology, DHT plays a significant role in women, particularly in hair follicle health, skin condition, and overall hormonal balance. Elevated levels of DHT in women can lead to androgenic effects such as hirsutism (excessive hair growth in areas typical for males), acne, and in some cases, androgenic alopecia (pattern hair loss). These symptoms are often observed in conditions like polycystic ovary syndrome (PCOS), which is characterized by an overproduction of androgens. In the context of a urine comprehensive hormone panel, measuring DHT levels allows for a nuanced understanding of androgenic activity over time. This is especially important in diagnosing and managing conditions where androgen levels fluctuate, such as in different phases of the menstrual cycle or in response to hormonal therapies. Elevated urinary DHT levels in females may warrant further investigation to determine underlying causes, which can include not only PCOS but also adrenal hyperplasia or tumors, insulin resistance, and obesity. Treatment for elevated DHT levels typically focuses on addressing the underlying hormonal imbalance. This might involve lifestyle interventions like diet modifications and exercise to improve insulin sensitivity and reduce body weight, as obesity can exacerbate androgenic symptoms. Pharmacological treatments can include androgen receptor blockers, 5-alpha-reductase inhibitors to reduce the conversion of testosterone to DHT, or hormonal contraceptives to regulate menstrual cycles and reduce androgen production. Each treatment plan should be personalized based on the individual's specific hormonal profile, health status, and the severity of symptoms. Monitoring DHT levels alongside other hormonal markers is crucial in evaluating the effectiveness of these treatments and ensuring a holistic approach to managing hormonal health in women.

Dihydrotestosterone (female)

Serum Plasma

Part of Metabolic Health

Potent androgen measured to assess excess androgens in females.

Dihydrotestosterone (male)

Serum

Part of Metabolic Health

Dihydrotestosterone (DHT), the potent androgen made from testosterone.

Dihydroxyphenylacetic (DOPAC)

Part of Organic Acids Test (OAT) - Nutritional and Metabolic Profile, Mosaic Diagnostics

Dopamine metabolite

Dihydroxyphenylacetic (DOPAC) (Females Under Age 13)